Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes
- 8 December 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 351 (1), 165-170
- https://doi.org/10.1016/j.bbrc.2006.10.014
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 25 references indexed in Scilit:
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Adiponectin Replenishment Ameliorates Obesity-Related HypertensionHypertension, 2006
- The metabolic syndrome and adipocytokinesFEBS Letters, 2006
- A New Anti-diabetic Zn(II)–Hinokitiol (β-Thujaplicin) Complex with Zn(O4) Coordination ModeChemistry Letters, 2005
- A Highly Potent Insulin–mimetic Zinc(II) Complex with a Zn(S2O2) Coordination Mode: Bis(1,6-dimethyl-3-hydroxy-5-methoxy-2-pentyl-1,4-dihydropyridine-4-thionato)zinc(II)Chemistry Letters, 2005
- A new insulin-mimetic bis(allixinato)zinc(II) complex: structure?activity relationship of zinc(II) complexesJBIC Journal of Biological Inorganic Chemistry, 2004
- Pathophysiological role of leptin in obesity-related hypertensionJournal of Clinical Investigation, 2000
- Resampling Methods in Sparse Sampling Situations in Preclinical Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1998
- Lipogenic Enzymes in Two Types of Genetically Obese Animals, Fatty Rats and Yellow KK MiceHormone and Metabolic Research, 1975
- General Survey of Diabetic Features of Yellow KK MiceEndocrinologia Japonica, 1970